ResMed is rated a buy due to strong fundamentals, expanding margins, robust cash flow, and resilience in recessionary environments. RMD's steady topline growth, high profitability, low debt, and ...

CPAP equipment should be cleaned regularly with soap and hot water or vinegar and water to prevent infections. The use of CPAP sanitizers like SoClean and Lumin may not reduce infection risk and needs ...

ResMed Inc. (NYSE:RMD) released its Q4 FY2025 earnings presentation on July 31, 2025, revealing robust financial performance despite a challenging macroeconomic environment. The global leader in ...

ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.

ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.

ResMed (NYSE:RMD) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, ...

There is a need to address the rising cases of sleep apnea in India. (Image Credits: Pixabay) ResMed on Tuesday announced that it has launched AirSense 11 in India. According to the company’s ...

ResMed, a company known for medical devices like CPAP machines, today announced the launch of the Kontor Head Strap, a new accessory designed for the Vision Pro. The Kontor Head Strap was created to ...

ResMed Inc (ASX: RMD) shares are marching higher again on Monday. In late morning trade, shares in the S&P/ASX 200 Index (ASX: XJO) sleep disorder treatment company are changing hands for $37.55 ...

ResMed makes continuous and bilateral positive airway pressure machines for non-invasive treatment of sleep apnea - a condition in which the airway gets blocked multiple times while sleeping.

Oct 24 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment. Shares of the ...

ResMed (RMD) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the ...